Active substance
Results for the substance lixisenatide
3 results
About this active substance
Lixisenatide is a medication used to treat type 2 diabetes. It belongs to the class of GLP-1 receptor agonists (glucagon-like peptide-1) and helps lower blood sugar levels by stimulating insulin secretion and slowing gastric emptying.
The medication is administered as subcutaneous injections, usually once daily before the first meal. It is used in combination with other antidiabetic medications or as monotherapy, depending on the patient's needs.
Side effects may include nausea, vomiting, diarrhea, or injection site reactions. In rare cases, severe allergic reactions or pancreatitis may occur.
Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before using lixisenatide.
The medication is administered as subcutaneous injections, usually once daily before the first meal. It is used in combination with other antidiabetic medications or as monotherapy, depending on the patient's needs.
Side effects may include nausea, vomiting, diarrhea, or injection site reactions. In rare cases, severe allergic reactions or pancreatitis may occur.
Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before using lixisenatide.
-
-
LYXUMIA 10mcg+LYXUMIA 20mcg PACKAGING FOR INITIATING TREATMENT solution for injection AVENTIS ORIGINAL MEDICINE
-
LYXUMIA 10mcg 50mcg/ml solution for injection AVENTIS ORIGINAL MEDICINE